Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002162951 | SCV002411273 | likely benign | Neuroblastoma, susceptibility to, 3 | 2021-08-28 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003933492 | SCV004763880 | likely benign | ALK-related disorder | 2023-04-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |